These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer. Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852 [TBL] [Abstract][Full Text] [Related]
3. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565. Sodhi A; Basu S Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519 [TBL] [Abstract][Full Text] [Related]
8. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes. Flexman JP; Manning LS; Robinson BW Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789 [TBL] [Abstract][Full Text] [Related]
9. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906 [TBL] [Abstract][Full Text] [Related]
10. In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro. Hancock GE; Molloy A; Ab BK; Kiessling R; Becx-Bleumink M; Cohn ZA; Kaplan G Cell Immunol; 1991 Feb; 132(2):277-84. PubMed ID: 1988157 [TBL] [Abstract][Full Text] [Related]
11. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179 [TBL] [Abstract][Full Text] [Related]
12. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy. Pavletic Z; Benyunes MC; Thompson JA; Lindgren CG; Massumoto C; Alderson MR; Buckner CD; Fefer A Exp Hematol; 1993 Sep; 21(10):1371-8. PubMed ID: 8359237 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of exercise-induced augmentation of lymphokine activated killer (LAK) cell activity in the horse. Horohov DW; Keadle TL; Pourciau SS; Littlefield-Chabaud MA; Kamerling SG; Keowen ML; French DD; Melrose PA Vet Immunol Immunopathol; 1996 Oct; 53(3-4):221-33. PubMed ID: 8969043 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2. Leung KH Cell Immunol; 1989 Oct; 123(2):384-95. PubMed ID: 2507171 [TBL] [Abstract][Full Text] [Related]
15. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes. Brooks B; Parry H; Lawry J; Rees R Immunology; 1992 Feb; 75(2):343-8. PubMed ID: 1551696 [TBL] [Abstract][Full Text] [Related]
16. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity. Tunru IS; Suzuki H; Yano S Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201 [TBL] [Abstract][Full Text] [Related]
17. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177 [TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor. Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733 [TBL] [Abstract][Full Text] [Related]
19. Effect of ASTA-Z 7575 (INN Maphosphamide) on human lymphokine-activated killer cell induction. Singh KP; Gupta RK; Shau H; Ray PK Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):525-38. PubMed ID: 8301017 [TBL] [Abstract][Full Text] [Related]
20. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. Ellis TM; McKenzie RS; Simms PE; Helfrich BA; Fisher RI J Immunol; 1989 Dec; 143(12):4282-6. PubMed ID: 2512355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]